Novo Nordisk

News

Novo Nordisk moves chronic kidney disease drug ziltivekimab ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.

News

Businessmen trading stocks online. Stock brokers looking at graphs, indexes and numbers on multiple computer screens. Colleagues in discussion in traders office. Business success concept.

Arecor hopes London stock market float will raise profile of...

UK biotech Arecor Therapeutics has announced plans to float on the London stock market, to fund plans to develop novel formulations of insulins and other biological drugs with enhanced prop

News

Novo Nordisk ups forecasts after Q1 profit boost

After an indifferent period Novo Nordisk has kicked off 2021 on the front foot, raising its financial forecast after posting better than expected Q1 earnings and sales.

News

Gilead pushes on with NASH partnership with Novo Nordisk

Gilead is one of many pharmas chasing mega-bucks promised by the fatty liver disease known as NASH – but after

News

Novo Nordisk’s semaglutide effective against obesity in new ...

Novo Nordisk’s hopes of getting semaglutide approved for obesity management may have received a boost, with a new, large trial showing the drug was able to cut body weight significantly over the

News

The liver is a vital organ of the digestive system present in vertebrates and some other animals. It has a wide range of functions, including detoxification, protein synthesis, and production of biochemicals necessary for digestion.

High hopes as Inventiva takes NASH contender into phase 3

Analysts are continuing to back Inventiva’s lanifibranor as a potential “best-in-class” drug for the fatty liver disease NASH, as the company prepares for the launch of a phase 3 trial in s

Novo Nordisk moves chronic kidney disease drug ziltivekimab ...

Arecor hopes London stock market float will raise profile of...

Novo Nordisk ups forecasts after Q1 profit boost

Gilead pushes on with NASH partnership with Novo Nordisk

Novo Nordisk’s semaglutide effective against obesity in new ...

High hopes as Inventiva takes NASH contender into phase 3

Agreement reached on EU's new pharma legislation

How to meet your physicians where they are online

Novo Nordisk

Editor's Picks